Citigroup »

Lisata Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.0k 1.4k 3.47

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Lisata Therapeutics

BML Capital Management
Vanguard Group
Renaissance Technologies
BlackRock
Geode Capital Management
Dimensional Fund Advisors
State Street Corporation
Cook Wealth Management Group
HighTower Advisors
Bank of America Corporation
Morgan Stanley
Founders Capital Management
Citigroup
Tower Research Capital
Royal Bank of Canada

View all funds holding Lisata Therapeutics